Brompheniramine
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313404This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19BrN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H57G17P2FN, chemically known as 3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but generally known as brompheniramine, which bears US NIH Compound Identifier 6834. Brompheniramine most often comes in base and maleate forms. European Medicines Agency schedules Brompheniramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05924MIG. The term BROMPHENIRAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules brompheniramine in its Anatomical Therapeutic Chemical (ATC) Classification. BROMPHENIRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brompheniramine under HS 29333999 and SITC 51574. As of Q4 2014, BROMPHENIRAMINE remains the US FDA Preferred Term for this commodity. Brompheniramine bears US NLM identifiers UMLS ID C0006246 and NCI Concept Code C61655. SMILES: BRC1CCC(C(CCN(C)C)C2NCCCC2)CC1.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.